Get the Stockscreener App
4.15
13.92%
3.36
Opgen Inc stock is traded at $4.15, with a volume of 9,512.
It is up +13.92% in the last 24 hours and down -36.27% over the past month.
See More
Previous Close:
$0.79
Open:
$4.12
24h Volume:
9,512
Relative Volume:
66.00
Market Cap:
$N/A
Revenue:
$3.07M
Net Income/Loss:
$-26.16M
P/E Ratio:
-0.6375
EPS:
-6.51
Net Cash Flow:
$-17.84M
1W Performance:
+13.92%
1M Performance:
-36.27%
6M Performance:
-57.97%
1Y Performance:
+14.04%
1-Day Range:
$3.94
$4.27
1-Week Range:
$3.94
$4.27
52-Week Range:
$3.94
$4.27
Opgen Inc Stock (OPGN) Company Profile
Compare OPGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPGN
Opgen Inc
|
4.15 | 0 | 3.07M | -26.16M | -17.84M | -6.51 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Opgen Inc Stock (OPGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-19 | Initiated | Alliance Global Partners | Buy |
| Feb-07-18 | Reiterated | H.C. Wainwright | Buy |
| Jun-29-16 | Initiated | Rodman & Renshaw | Buy |
Opgen Inc Stock (OPGN) Latest News
OpGen (NASDAQ:OPGN) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World
OpGen (NASDAQ:OPGN) Now Covered by StockNews.com - Defense World
OpGen Delays Yearly Report Amid Operational Challenges - TipRanks
OpGen (NASDAQ:OPGN) Earns Sell Rating from Analysts at StockNews.com - Defense World
Antimicrobial Susceptibility Testing Market Expecting Huge Demand in Upcoming Years Accelerate Diagnostics - openPR.com
Antimicrobial Resistance Surveillance Global Market Report 2025: Steady Growth, And Increased Awareness Propel - EIN News
OpGen (NASDAQ:OPGN) Now Covered by Analysts at StockNews.com - Defense World
OpGen, Inc. to Host Earnings Call - ACCESS Newswire
Blood Culture Screening Devices Market Rewriting its Growth Cycle | bioMérieux SA, OpGen, T2 Biosystems - Newstrail
StockNews.com Begins Coverage on OpGen (NASDAQ:OPGN) - Defense World
Antimicrobial Resistance Surveillance Market is expected to generate a revenue of USD 9.86 Billion by 2032, Globally, at 5.65% CAGR: Verified Market Research - The Malaysian Reserve
Antimicrobial Resistance Surveillance Market is expected to generate a revenue of USD 9.86 Billion by 2032, Globally, at 5.65% CAGR: Verified Market Research® - PR Newswire UK
OpGen (NASDAQ:OPGN) Coverage Initiated by Analysts at StockNews.com - Defense World
Blood Stream Infection Testing Global Market Report 2025: Trends, Forecasts, and Competitor Analysis - EIN News
Blood Culture Test Market to Reach $8.18 Billion | CAGR of 9.3% - openPR
StockNews.com Initiates Coverage on OpGen (NASDAQ:OPGN) - Defense World
Global Antimicrobial Resistance Surveillance Market to Reach USD 9.50 Billion by 2032, Growing at a CAGR of 5.47% - WICZ
Antimicrobial Resistance Diagnostic Markets, Strategies and Trends Report 2024 with Executive Guides and 5 Year Forecasts - GlobeNewswire Inc.
OpGen Faces Delisting from Nasdaq Following Appeal Decision - Defense World
OpGen faces Nasdaq delisting, to trade OTC By Investing.com - Investing.com Australia
OpGen faces Nasdaq delisting, to trade OTC - Investing.com India
OpGen’s subsidiary Ares Genetics provides update on collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR) - Marketscreener.com
Electronic evaluation of infection risk from room environment and - ResearchGate
OpGen Inc sees significant stock purchase by AEI Capital Ltd - Investing.com South Africa
OpGen Inc shareholder AEI Capital Ltd increases stake with $1.9 trillion purchase - Investing.com Nigeria
OpGen Inc adds new COO and Company Secretary By Investing.com - Investing.com Nigeria
OpGen Inc adds new COO and Company Secretary - Investing.com India
OpGen Appoints New COO and Company Secretary - TipRanks
OpGen (NASDAQ:OPGN) Coverage Initiated at StockNews.com - Defense World
OpGen (OPGN) EBITDA : $-8.88 Mil (TTM As of Sep. 2024) - GuruFocus.com
OpGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
OpGen Inc (OPGN) Quarterly 10-Q Report - Quartzy
Biophotonics Global Market Observe Highest Growth of $130.07 - openPR
OpGen secures additional $6 million financing, extends agreement to 2025 By Investing.com - Investing.com Australia
OpGen secures additional $6 million financing, extends agreement to 2025 - Investing.com India
AEI Capital Ltd reports stock transactions in OpGen Inc By Investing.com - Investing.com South Africa
Opgen Inc Stock (OPGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.55%
Cap:
|
Volume (24h):